Literature DB >> 1729884

Biochemical and immunological characterization of serum biotinidase in profound biotinidase deficiency.

P S Hart1, J Hymes, B Wolf.   

Abstract

The biochemical and immunological characterization of biotinidase was performed in sera from 100 normal individuals, 68 children with profound biotinidase deficiency (less than 10% of mean normal activity) who were identified symptomatically and by newborn screening, and 63 of their parents. On isoelectric focusing, serum enzyme from normal individuals exhibits extensive microheterogeneity, consisting of at least four major and five minor isoforms at pH 4.15-4.35. Patients with profound biotinidase deficiency can be classified into at least nine distinct biochemical phenotypes, on the basis of (a) the presence or absence of cross-reacting material (CRM) to biotinidase, (b) the number of isoforms, and (c) the distribution frequency of the isoforms. None of the patients with CRM had an abnormal Km of the substrate for the enzyme. All of the parents had normal isoform patterns. The mean activities, CRM concentrations, and specific activities were not significantly different between parents of CRM-positive children and parents of CRM-negative children. There is no relationship between either the age at onset or the severity of symptoms and the isoform patterns or CRM status of the symptomatic children. The isoform patterns of children identified by newborn screening are not different from those of symptomatic children.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729884      PMCID: PMC1682526     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  9 in total

1.  Biotinidase activity in animal tissues.

Authors:  M KOIVUSALO; J PISPA
Journal:  Acta Physiol Scand       Date:  1963-05

2.  Isoforms of human serum biotinidase.

Authors:  P S Hart; J Hymes; B Wolf
Journal:  Clin Chim Acta       Date:  1991-03-29       Impact factor: 3.786

3.  Immunological comparison of biotinidase in serum from normal and biotinidase-deficient individuals.

Authors:  B Wolf; J B Miller; J Hymes; J Secor McVoy; Y Ishikawa; E Shapira
Journal:  Clin Chim Acta       Date:  1987-04-15       Impact factor: 3.786

4.  Screening for biotinidase deficiency in newborns: worldwide experience.

Authors:  B Wolf; G S Heard
Journal:  Pediatrics       Date:  1990-04       Impact factor: 7.124

5.  The quantitation of biotinidase activity in dried blood spots using microtiter transfer plates: identification of biotinidase-deficient and heterozygous individuals.

Authors:  D A Pettit; P S Amador; B Wolf
Journal:  Anal Biochem       Date:  1989-06       Impact factor: 3.365

Review 6.  Biotinidase deficiency: a novel vitamin recycling defect.

Authors:  B Wolf; R E Grier; J R Secor McVoy; G S Heard
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

7.  Comparative study on human milk and serum biotinidase.

Authors:  J Oizumi; K Hayakawa; M Hosoya
Journal:  Biochimie       Date:  1989 Nov-Dec       Impact factor: 4.079

8.  Purification and characterization of human serum biotinidase.

Authors:  J Chauhan; K Dakshinamurti
Journal:  J Biol Chem       Date:  1986-03-25       Impact factor: 5.157

9.  Purification of biotinidase from human plasma and its activity on biotinyl peptides.

Authors:  D V Craft; N H Goss; N Chandramouli; H G Wood
Journal:  Biochemistry       Date:  1985-05-07       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.